+
Site Tour

EuroPCR 2022: Expand your mitral portfolio with Tendyne™

A short expert interview with Alison Duncan and Lenard Conradi discussing Tendyne™ and how it can optimize patient outcomes and support the patient peri-procedurely.

Related Videos

EuroPCR 2022: Mitral replacement

EuroPCR 2022: Leading clinical evidence

EACTS 2022: SMV repair vs replacement

Mechanical Heart Valve Patient Story: Sadie

TAVI Summit - TAVR in bicuspid

Echo course mitral TEER – procedural approach

EACTS 2021: Impact of MVR Guidelines

Navigating the Anatomy | Mitral focus

Now you've got Navitor.
Stable delivery.

EuroPCR 2023: Mitral regurgitation

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

PCR LV 2021: Navitor™ Looking ahead

EuroEcho 2021: Tricuspid regurgitation: The Patient

PCR LV 2021: Navitor™ 30-day outcomes

Epic Mitral – 10-Year Clinical Outcomes

CONNEXT


LIVE
RELATED EVENTS

TAVI Summit - TAVR in bicuspid

AV VALVES 2023: The Genesis of TEER

AV VALVES 2023: HoloLens Technology

AV Valves Summit 2024 | Closing of Day 2

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline